Founded in 2016 by a group of experienced engineers and bioinformaticians under the leadership of Claudio Alberti, our CTO, GenomSys is a Swiss company developing state-of-the-art technology and services for the efficient analysis and secure management of genomic information.
The company is a pioneer in the development of open standards for genomic data storage and processing – it led the process of standardization of ISO/IEC 23092 (MPEG-G) – and in the implementation of compliant software and tools for its effective application.
In October 2019, GenomSys secured a CHF9.3 million Series A funding to take the development of the company to the next stage.
Now GenomSys is taking the next step, enabling laboratories and end-users to take advantage of the new standard: MPEG-G native analytical pipelines for more efficient storage and focused analyses via selective access, and the ability for people to store and analyze their own genomic data in their smartphones, bringing genomics into the mobile world.
In doing so, GenomSys defines a new paradigm with a highly differentiated solution: a consistent value proposition emphasizing privacy and convenience to truly deliver personalized medicine to individuals by leveraging the uniqueness of the new digital genomic standard and the pervasiveness of mobile, directly or through business partners.
GenomSys headquarters are in the Swiss Health Valley, at the center of a hub of technology and genomic innovation around the research centers of the Ecole Polytechnique Fédérale de Lausanne and the Swiss Genome Center. The company recently opened an additional scientific center in Ticino, an emerging hub for innovation in biotechnology and digital developments in the south of Switzerland.